Almirall gets validation for 2050 net zero goal
The Spanish pharmaceutical company has also committed to reducing absolute Scope 1 and 2 emissions by 50% and Scope 3 emissions by 28% by 2030.
AstraZeneca to invest USD 400m in afforestation project
AstraZeneca recently announced plans to invest USD 400 million in the afforestation initiative AZ Forest, with projects in Brazil, India, Vietnam, Ghana and Rwanda.
Qiagen receives approval for its net zero target
The global pharmaceutical company has pledged to hit net zero greenhouse gas (GHG) emissions by 2050, its absolute reductions measured from a 2020 base year.
Medtronic commits to net zero by 2045
The American medical device manufacturer has set an interim goal of being carbon neutral by 2030 as part of its commitment to the SBTi.
Elekta’s climate targets validated by SBTi
The SBTi has validated various 2030 targets on Scopes 1, 2 and 3 of the Swedish medical equipment manufacturer.
Astellas commits to achieve net zero by 2050
The Japanese pharmaceutical company Astellas Pharma announced its commitment to reducing GHG emissions in its scopes 1, 2, and 3 by 90% by 2050.
Viatris’s near-term targets approved by SBTi
The US-based pharmaceutical company, born of the merger of Mylan and UpJohn, has commited to reduce scope 1 and 2 GHG emissions by 42% by 2030.
Pfizer accelerates climate action to achieve net-zero by 2040
Pfizer announced a commitment to achieve the voluntary Net-Zero Standard by 2040, ten years earlier than the timeline described in the standard. Pfizer aims to decrease its GHG emissions by…
61 US organisations join ‘Health Sector Climate Pledge’
Pfizer, AstraZeneca, Kaiser Permanente, Philips, amongst group to join Biden Administration’s pledge to reduce GHG emissions by 50% by 2030.
NHS launches ‘green plan’ to decarbonise estates
The plan is part of the NHS's ‘Delivering a Greener NHS’ programme, which aims to achieve net-zero by 2040.
Amgen issues inaugural $750m green bond
Amgen announced the issuance of its inaugural $750 million green bond, with a 3.00% semi-annual coupon and maturing in 2029.
Sanofi pulls carbon neutral goal forward to 203
Among Pharmaceutical group Sanofi's CSR strategy updates is also a new 2050 net zero objective.
Bupa targets net-zero emissions by 2040
International healthcare company Bupa has joined the UN's Race to Zero programme and has pledged to reach net-zero emissions by 2040.
Charles River Laboratories signs 250 MWh solar project
Pharmaceutical research tools provider Charles River Laboratories International announced a long-term solar energy contract to address the entirety of its North American electric power requirements with renewable energy by 2023.
JBS, Pfizer, others join Business Ambition for 1.5°C
New Business Ambition for 1.5°C campaign signees include: Kenya Electricity Generating Company (electricity-Kenya), Yum China Holdings (restaurants-China), JBS (meat processing-Brazil), Vistra (electricity-US), Boehringer Ingelheim (pharameuticals-US), Pfizer (pharameuticals-US), Corteva Agriscience (chemicals-US), …